JORDAN CRUZ: Open Payments
NPI 1700235249 · MANDEVILLE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$96 in 5 payments from 5 companies in 2025. Trend: 2023 $14 · 2024 $97 · 2025 $96
Food & beverage: $96
| Company | Payments | Amount |
|---|---|---|
| ARS Pharmaceuticals Operations, Inc. | 1 | $28 |
| Optinose US, Inc. | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| GENZYME CORPORATION | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: DUPIXENT, NEFFY, Xhance, TEZSPIRE.
Industry payments across LA — which companies pay providers there.
